著者

安場 広髙

出版者

日本耳鼻咽喉科感染症・エアロゾル学会

雑誌

日本耳鼻咽喉科感染症・エアロゾル学会会誌 (ISSN:21880077)

巻号頁・発行日

vol.5, no.1, pp.1-4, 2017-01-20 (Released:2020-08-04)

参考文献数

18

---

Eosinophilic chronic rhinosinusitis (ECRS) and bronchial asthma often occur concomitantly. As a simple and simultaneous treatment of both diseases, we describe a new technique for the nasal exhalation of inhaled corticosteroid (ICS). PIV-laser visualized inhaled HFA-134a-beclomethasone dipropionate (HFA-BDP) aerosol or Symbicort turbuhaler® is still present in the exhaled breath because of its small particle size. This nasal exhalation technique of orally-inhaled ICS improved CT score and sense of smell in ECRS and then improved peripheral airway obstruction and symptoms in bronchial asthma. Thus, we demonstrated the utility of nasal exhalation of ICS for asthmatic patients with ECRS as a concurrent single therapy, which illustrates the new concept of “Airway Medicine”.